Glial Fibrillary Acidic Protein Autoimmunity After Aseptic Meningitis: A Report of 2 Cases

Neurol Neuroimmunol Neuroinflamm. 2023 Nov 10;11(1):e200180. doi: 10.1212/NXI.0000000000200180. Print 2024 Jan.

Abstract

Objectives: We describe 2 patients with glial fibrillary acidic protein (GFAP) autoimmunity secondary to aseptic viral meningitis or meningoencephalomyelitis.

Methods: This study involved a retrospective chart review.

Results: Two female patients, 45 and 55 years of age, developed aseptic meningoencephalomyelitis or meningitis; in one patient, it was likely caused by herpes simplex virus 2. The patients were recovering from the infectious condition when they, 51 and 5 days after onset, had new symptoms with detection of GFAP antibodies in the CSF; CSF and serum samples from the initial lumbar punctures had been negative for GFAP antibodies. Both patients recovered with steroid treatment (in one case, plus rituximab; in the other, plus azathioprine) including resolution of MRI and CSF abnormalities.

Discussion: These 2 patients had GFAP autoimmunity secondary to viral meningoencephalomyelitis or meningitis. This suggests that GFAP astrocytopathy might not always be a primary disease entity; it may follow another brain injury that triggers this autoimmune response.

Publication types

  • Case Reports

MeSH terms

  • Autoimmune Diseases of the Nervous System*
  • Autoimmunity
  • Female
  • Glial Fibrillary Acidic Protein
  • Humans
  • Meningitis, Aseptic* / etiology
  • Meningitis, Viral*
  • Retrospective Studies

Substances

  • Glial Fibrillary Acidic Protein